Journal of Cancer Treatment and Research

Volume 8, Issue 4, December 2020

  • Maternal Death Surveillance System Evaluation at Addis Ababa City Administration, Ethiopia, 2018

    Kefyalew Amene Bogale, Tesfahun Abye Meshesha, Abiy Girmay

    Issue: Volume 8, Issue 4, December 2020
    Pages: 64-73
    Received: 21 July 2020
    Accepted: 4 August 2020
    Published: 23 November 2020
    Abstract: Introduction: Public health surveillance is an ongoing, systematic collection, analysis, interpretation, and dissemination of data regarding a health-related event for use in public health. Maternal Death Surveillance and Response (MDSR) is form of continuous surveillance linking the health information system to quality improvement processes from l... Show More
  • Combined Application of Anticancer Vaccines of IEPOR Series and Doxorubicin in Rats with Transplanted Walker Carcinosarcoma

    Olena Kruts, Volodymyr Konovalenko, Volodymyr Bazas, Sergii Konovalenko, Gennadii Didenko, Oleksandr Lytvynenko, Anna Artamonova, Oksana Gerashchenko

    Issue: Volume 8, Issue 4, December 2020
    Pages: 74-78
    Received: 26 October 2020
    Accepted: 11 November 2020
    Published: 4 December 2020
    Abstract: Anticancer xenogeneic vaccine – is an agent, containing antigens of embryonic origin that underwent biotransformation under the action of cytotoxic proteins of В. subtilis B-7025. Anticancer efficacy of the vaccine is implemented by breaking immune system tolerance to own tumor antigens due to the antigenic similarity between tumor and embryonic pr... Show More
  • Effectiveness of Late Line Palliative Chemotherapy by Specialised Approach to Cancer of Unknown Primary: A Case Report

    Itaru Sato, Naoki Nakaya, Yoko Obara, Natumi Kurosaka, Souichirou Ueno, Hideo Nakajima

    Issue: Volume 8, Issue 4, December 2020
    Pages: 79-81
    Received: 20 November 2020
    Accepted: 4 December 2020
    Published: 11 December 2020
    Abstract: Background: Cancers of unknown primary (CUPs) are defined as histologically confirmed metastatic tumours whose primary site cannot be identified during standard pretreatment evaluation. No specific regimen can be recommended as standard of care. Taxanes and platinum-based regimens are commonly used in the first-line treatment of CUPs, but there is ... Show More